Definition of Shock

Normal circulatory function depends on coordinated interaction between the heart as the central pump and the microcirculation at the tissue level to deliver oxygen and nutrients and remove metabolic waste. Shock is an acute failure of circulatory function to adequately deliver oxygen or nutrients to tissues resulting cellular energy failure and metabolic dysfunction.

In children, strong compensatory mechanisms are able to preserve blood pressure and shock may occur without hypotension. Therefore, Early recognition therefore relies on perfusion abnormalities, vital sign changes, and mental status rather than blood pressure alone.

Goals of Emergency Therapy


Clinical and Pathophysiologic Considerations

Determinants of Oxygen Delivery

Adequate tissue oxygenation depends on cardiac output (CO) and microvascular blood flow:

CO = Stroke Volume × Heart Rate

Stroke volume is influenced by:

These variables are regulated by sympathetic tone, endogenous catecholamines, nitric oxide, pH, oxygen tension, calcium homeostasis, and inflammatory mediators.

Pediatric Consideration

Infants have limited ability to increase stroke volume and rely heavily on heart rate to augment cardiac output, therefore,  tachycardia is a key early sign of shock.

Compensatory Responses and Shock Progression

Decreases in preload, afterload, or contractility trigger compensatory mechanisms such as increased heart rate, increased SVR, and redistribution of blood flow. As shock progresses, these mechanisms fail, leading from compensated to uncompensated shock.

Blood Pressure and Perfusion

Blood pressure reflects the interaction of CO and SVR but is a late marker of shock in children. Normal blood pressure does not exclude significant hypoperfusion.

Compensated Shock (Normal BP)

Distributive Shock Variants

Low SVR may produce:

Biochemical Indicators

Uncompensated Shock (Hypotension)

Hypotension indicates failure of compensatory mechanisms and impending cardiovascular collapse.

Hypovolemia and Vascular Dysfunction

All shock states involve absolute or functional hypovolemia.

Absolute Hypovolemia

Functional Hypovolemia

Microcirculatory Dysfunction

Maldistribution of capillary blood flow is common to all shock types and is driven by endothelial activation, inflammatory cytokines, PAMPs, DAMPs, microthrombi, and glycocalyx injury. This contributes to regional ischemia and progression to multiorgan dysfunction syndrome (MODS).

Reperfusion Injury

Restoration of blood flow may trigger oxidative and inflammatory injury, amplifying tissue damage even after global perfusion improves.

Cytopathic Hypoxia

Mitochondrial dysfunction may impair oxygen utilization despite adequate delivery, leading to impaired ATP production and organ dysfunction. This phenomenon helps explain persistent organ injury in sepsis and trauma despite normalized hemodynamics.

Shock Type Examples HR BP CO Capillary Refill Extremity Temp SVR Treatment
Hypovolemic Hemorrhage
Dehydration
Delayed Cool High Stop bleeding
Fluid resuscitation (crystalloids)
Blood products when indicated
Cardiogenic Myocarditis
Dysrhythmias
Cardiomyopathy
Delayed Cool High Inotropes (epinephrine, milrinone)
Caution with fluids
Treat arrhythmias
ECMO for refractory cases
Distributive Sepsis
Anaphylaxis
↓ or normal ↓ or ↑ (early sepsis) Flash or delayed Warm or cool Low or high Sepsis: antibiotics, fluids, vasopressors
Anaphylaxis: epinephrine, fluids, antihistamines, steroids
Neurogenic Spinal cord injury
Traumatic brain injury
Flash or normal Warm Low Fluid resuscitation
Vasopressors (norepinephrine)
Spinal stabilization
Obstructive Cardiac tamponade
Tension pneumothorax
Pulmonary embolus
Ductal-dependent congenital lesions
Delayed Cool High Pericardiocentesis
Needle decompression / chest tube
Anticoagulation or thrombectomy
Prostaglandins for ductal-dependent lesions
Dissociative Carbon monoxide poisoning
Cyanide toxicity
Normal or Normal Normal Low to normal CO: high-flow oxygen, hyperbaric therapy
Cyanide: hydroxocobalamin, sodium thiosulfate

Types of Shock (causes, pathophysiology, features)

Hypovolemic Shock

Paragraph Summary

Hypovolemia, or decreased circulating blood volume, is the most common cause of shock in children. Worldwide, the leading etiology is gastrointestinal fluid loss from vomiting and diarrhea due to infection. Other causes include hemorrhage (trauma, postsurgical, gastrointestinal), plasma losses (burns, hypoproteinemia, pancreatitis), and extragastrointestinal water losses (glycosuric diuresis, heat stroke).

Acute hypovolemia reduces cardiac output due to decreased preload, triggering compensatory increases in heart rate and systemic vascular resistance (SVR). Baroreceptor-mediated sympathetic activation increases cardiac chronotropy and vasoconstriction, while adrenal epinephrine release augments these responses. Activation of the renin–angiotensin–aldosterone (RAA) system and antidiuretic hormone (ADH) promotes renal sodium and water retention. Angiotensin II further increases SVR through direct vasoconstriction.

Bullet-Point Summary

Cardiogenic Shock

Paragraph Summary

Cardiogenic shock results from decreased cardiac output due to impaired myocardial contractility. Obstructive congenital heart lesions causing outflow obstruction are better classified as obstructive shock. Although myocardial depression may occur in all shock states, primary cardiogenic shock is caused by viral myocarditis, ALCAPA, incessant arrhythmias, drug ingestions (e.g., cocaine), metabolic derangements (e.g., hypoglycemia), and postoperative cardiac surgery complications.

Clinical signs include pulmonary rales, gallop rhythm, hepatomegaly, jugular venous distention, peripheral edema, and cardiomegaly on chest radiograph. Laboratory findings such as elevated CK, troponin, or BNP may indicate myocardial dysfunction but are not universally present.

As in hypovolemic shock, sympathetic activation, RAA system upregulation, ADH release, and natriuretic peptide secretion increase SVR to compensate for low cardiac output. However, the volume deficit in cardiogenic shock is functional rather than absolute.

Bullet-Point Summary

Obstructive Shock

Paragraph Summary

Obstructive shock occurs when an acute mechanical obstruction to ventricular outflow impairs cardiac output. Causes include pulmonary embolus, cardiac tamponade, tension pneumothorax, and left-sided obstructive congenital lesions such as critical aortic stenosis, coarctation, interrupted aortic arch, and hypoplastic left heart syndrome.

A sudden decrease in cardiac output leads to increased SVR and functional hypovolemia. Rapid identification of the underlying cause is essential. Ductal-dependent congenital lesions typically present at 1–3 weeks of age after ductus arteriosus closure.

Bullet-Point Summary

Distributive Shock

Paragraph Summary

Distributive shock results from inappropriate vasodilation, peripheral blood pooling, and microvascular shunting. Common causes include sepsis, anaphylaxis, and drug ingestions. It often coexists with hypovolemic or cardiogenic components.

Bullet-Point Summary

Pediatric Sepsis

Paragraph Summary

Pediatric sepsis has traditionally been defined using SIRS criteria. Severe sepsis includes organ dysfunction, and septic shock refers to cardiovascular dysfunction. Many children with sepsis have negative cultures, but microbial components trigger inflammatory and coagulation cascades leading to capillary leak, myocardial depression, and vasomotor instability.

Classic septic shock presents with high cardiac output and low SVR (“warm shock”), but more than half of children exhibit low cardiac output and high SVR (“cold shock”). Sepsis-3 redefined adult sepsis as life-threatening organ dysfunction from a dysregulated host response, with pediatric updates pending.

Bullet-Point Summary

Anaphylaxis

Paragraph Summary

In anaphylaxis, mast cell degranulation releases histamine, proteases, and proteoglycans, followed by prostaglandins and leukotrienes. These mediators cause urticaria, airway edema, wheezing, profound vasodilation, and capillary leak. Reflex tachycardia increases cardiac output.

Bullet-Point Summary

Neurogenic Shock

Paragraph Summary

Neurogenic shock is caused by sudden loss of sympathetic stimulation to vascular smooth muscle, resulting in profound vasodilation and decreased SVR. Unopposed vagal tone leads to bradycardia or absence of the expected tachycardic response. It may occur after severe traumatic brain injury or cervical spinal cord injury.

Bullet-Point Summary

Dissociative Shock

Paragraph Summary

Dissociative shock occurs when toxic metabolites or drugs impair cellular oxygen delivery or utilization despite normal or supranormal tissue perfusion. Examples include severe anemia, methemoglobinemia, and carbon monoxide poisoning. In these conditions, cells cannot effectively use oxygen, resulting in metabolic failure.

Bullet-Point Summary

Clinical Considerations in Shock Recognition

Vital Signs

History and Physical Examination

Hemorrhagic Shock

Hypovolemic Shock

Cardiogenic Shock

Obstructive Shock

Neurogenic Shock

Anaphylaxis

Septic Shock

Organ Dysfunction Criteria in Pediatric Septic Shock

Cardiovascular Dysfunction
Respiratory Dysfunction
Neurologic Dysfunction
Hematologic Dysfunction
Renal Dysfunction
Hepatic Dysfunction

Biomarkers and Laboratory Indicators in Early Shock Recognition

Neonates With Shock


Treatment: Principles of Shock Management

Vascular Access

Volume Resuscitation

Vasoactive Agents

Key principle: Epinephrine is first-line for fluid-refractory pediatric septic shock. Norepinephrine is preferred in low-SVR (“warm”) shock. Agents may start peripherally or via IO in dilute form, but should transition to central access when available.

Agent Dose Range Mechanism Primary Use Key Considerations
Epinephrine 0.05–1 µg/kg/min α₁, β₁, β₂ stimulation
  • β effects dominate at low doses → vasodilation
  • α effects dominate at higher doses → vasoconstriction
  • First-line for fluid-refractory shock
  • Cold shock (low CO, high SVR)
  • Potent inotrope and chronotrope
  • May increase lactate (metabolic effect)
  • May inhibit insulin → transient hyperglycemia
Norepinephrine 0.05–1 µg/kg/min α₁, β₁ stimulation
  • Warm shock with low blood pressure
  • Low SVR states (septic, distributive, neurogenic shock)
  • Strong vasopressor with mild inotropy
  • Preferred when vasodilation predominates
Dopamine 5–10 µg/kg/min α₁, β₁, β₂, D₁ stimulation
  • Receptor effects vary by dose
  • Alternative agent for fluid-refractory shock
  • Inotrope and chronotrope
  • Vasoconstrictor at higher doses
  • Higher risk of arrhythmias
  • Inferior to epinephrine in pediatric septic shock trials
Vasopressin 0.0002–0.004 units/kg/min
Max: 0.04 units/min
V1a receptor–mediated vasoconstriction
  • Non-adrenergic mechanism
  • Catecholamine-resistant shock
  • Adjunct in warm vasodilatory shock
  • Third-line agent
  • Limited pediatric evidence
  • May increase intracellular calcium
  • No improvement in time to hemodynamic stability in one trial
  • Trend toward higher mortality (not statistically significant)
Dobutamine 2.5–20 µg/kg/min β₁ stimulation; mixed α agonist/antagonist
  • Cold shock with normal BP
  • Adjunct to norepinephrine in cold shock with low BP and ScvO₂ <70%
  • Inotrope and chronotrope
  • Increases myocardial oxygen demand
  • Useful when afterload reduction is needed
Milrinone 0.25–1 µg/kg/min Type III phosphodiesterase inhibitor
  • Cold shock with normal BP
  • Adjunct for low ScvO₂ despite adequate MAP
  • Long half-life
  • Reduces afterload and improves contractility
  • Use caution in renal dysfunction

Additional Considerations for Vasoactive Therapy

Electrolyte Abnormalities

Airway Management in Shock

Source Control

Source control should begin as soon as IV access is obtained and fluid resuscitation is underway. Early identification and treatment of the underlying cause of shock is essential.

Hypovolemic Shock

Cardiogenic Shock

Distributive Shock (Septic Shock)

Initial Antimicrobial Choices in Septic Shock

Patient History Antibiotic Choices Additional Considerations
Previously healthy child with community‑acquired infection
  • Ceftriaxone + vancomycin
  • Oseltamivir during influenza season
  • Add clindamycin if toxin‑mediated syndrome suspected
Suspected intra‑abdominal infection
  • Piperacillin/tazobactam + vancomycin
  • OR ceftriaxone + metronidazole + vancomycin

Immunocompromised patient
(cancer, chronic disease, recent hospitalization, long‑term care, indwelling central line)
  • Cefepime + vancomycin
  • Add gentamicin for oncology/immunocompromised patients
  • Consider antifungal coverage if already on broad‑spectrum antibiotics
Neonate
  • Ampicillin + gentamicin
  • Consider acyclovir (risk of HSV)

Infants under 2–3 months require coverage for: Group B Streptococcus, coagulase‑negative Staphylococcus, Listeria, E. coli, H. influenzae, and HSV. They are at increased risk for CNS infection → ensure adequate CNS‑penetrating doses.

Anaphylactic Shock

Protocol-Based Care for Septic Shock

Although rapid recognition and reversal of shock applies to all shock types, pediatric septic shock has been the focus of extensive protocol development and quality improvement efforts. The principles below emphasize sepsis-specific management but are broadly applicable to other shock states.

Timely Antimicrobial and Fluid Resuscitation Therapy

Global Considerations

American College of Critical Care Medicine & Surviving Sepsis Campaign Recommendations

Quality Metrics in Pediatric Sepsis

Regulatory and Reporting Requirements

Monitoring for Shock Reversal

Frequent reassessment is essential to determine response to initial resuscitation. Improvement in clinical and laboratory parameters indicates successful reversal of shock.

Clinical & Laboratory Parameters of Improvement in Shock

Vital Sign Ranges by Age

Parameter Comment Target
Heart rate Tachycardia → hypovolemia or ongoing shock
Bradycardia → severe shock in infants or neurogenic shock in older children
Age‑specific
Respiratory rate Tachypnea may reflect pulmonary disease or metabolic acidosis Age‑specific
Systolic blood pressure Hypotension is a late sign in children
Wide pulse pressure (DBP <½ SBP) → low SVR (distributive/neurogenic shock)
Age‑specific
Mean arterial pressure Useful for titrating vasoactive therapy Age‑specific
Diastolic blood pressure Low DBP suggests vasodilation Age‑specific
Capillary refill Flash refill → warm shock
Delayed refill → cold shock
1–2 seconds
Extremity temperature Warm = vasodilation; Cool = vasoconstriction Normal warmth
Mental status Lethargy, confusion, agitation → poor perfusion Alert and age‑appropriate
Urine output Marker of renal perfusion <30 kg: >1 mL/kg/hr
≥30 kg: ≥30 mL/hr
Lactate Elevated lactate (>2–4 mmol/L) → inadequate oxygen delivery <2–4 mmol/L
OR ≥10% decrease every 1–2 hrs
Age HR (bpm) RR (breaths/min) SBP (mm Hg) MAP (mm Hg) DBP (mm Hg)
0–7 days 100–160 <60 >60 >40 >30
8–30 days 100–160 <60 >65 >45 >30
31 days–<2 yrs 90–160 <50 >70 >50 >35
2–<6 yrs <140 <30 >75 >50 >40
6–<13 yrs <130 <24 >85 >60 >45
>13 yrs <110 <20 >90 >65 >50
References (APA Style)

Vital Signs & Shock Monitoring References

  1. Nakagawa, S., & Shime, N. (2014). Respiratory rate criteria for pediatric systemic inflammatory response syndrome. Pediatric Critical Care Medicine, 15(2), 182–189.
  2. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. (2004). The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics, 114(2 Suppl 4th Report), 555–576.
  3. American Heart Association. (2020). Pediatric Advanced Life Support Provider Manual. American Heart Association.
  4. Weiss, S. L., Peters, M. J., Alhazzani, W., Agus, M. S. D., Flori, H. R., Inwald, D. P., ... & Hall, M. W. (2020). Surviving Sepsis Campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Medicine, 46(Suppl 1), 10–67.
  5. Schlapbach, L. J., Weiss, S. L., & Wolf, J. (2020). Reducing sepsis mortality in children — A global priority. New England Journal of Medicine, 382(12), 1073–1075.
  6. Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., ... & Dellinger, R. P. (2017). Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016. Critical Care Medicine, 45(3), 486–552.
  7. Weiss, S. L., Fitzgerald, J. C., Pappachan, J., Wheeler, D., Jaramillo-Bustamante, J. C., Salloo, A., ... & SPROUT Study Investigators. (2015). Global epidemiology of pediatric severe sepsis: The SPROUT study. Pediatric Critical Care Medicine, 16(7), 522–531.
  8. American College of Critical Care Medicine. (2017). Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock. Critical Care Medicine, 45(6), 1061–1093.
  9. Maitland, K., Kiguli, S., Opoka, R. O., Engoru, C., Olupot-Olupot, P., Akech, S. O., ... & FEAST Trial Group. (2011). Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine, 364(26), 2483–2495.
  10. Odetola, F. O., Gebremariam, A., Freed, G. L., & Singer, D. (2007). Patient and hospital correlates of clinical outcomes and resource utilization in severe pediatric sepsis. Pediatrics, 119(3), 487–494.

Central Venous Oxygen Saturation (ScvO₂) & Lactate

Advanced Monitoring Modalities

Fluid‑Refractory and Catecholamine‑Resistant Shock

Fluid‑refractory, catecholamine‑resistant shock is defined as persistent inadequate tissue perfusion despite ≥60 mL/kg of fluid resuscitation and high‑dose vasoactive support (epinephrine or norepinephrine ≥1 μg/kg/min). These patients have significantly higher mortality and require rapid escalation of care.

Reversible Etiologies

Mechanical Ventilation

Stress‑Dose Corticosteroids

Extracorporeal Membrane Oxygenation (ECMO)

Considerations for Intensive Care and Transport

Outcomes

Key Points

Comprehensive References (APA Style)
  1. Weiss, S. L., Peters, M. J., Alhazzani, W., Agus, M. S. D., Flori, H. R., Inwald, D. P., ... & Hall, M. W. (2020). Surviving Sepsis Campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Medicine, 46(Suppl 1), 10–67.
  2. American College of Critical Care Medicine. (2017). Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock. Critical Care Medicine, 45(6), 1061–1093.
  3. Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., ... & Dellinger, R. P. (2017). Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016. Critical Care Medicine, 45(3), 486–552.
  4. Schlapbach, L. J., Weiss, S. L., & Wolf, J. (2020). Reducing sepsis mortality in children — A global priority. New England Journal of Medicine, 382(12), 1073–1075.
  5. Weiss, S. L., Fitzgerald, J. C., Pappachan, J., Wheeler, D., Jaramillo-Bustamante, J. C., Salloo, A., ... & SPROUT Study Investigators. (2015). Global epidemiology of pediatric severe sepsis: The SPROUT study. Pediatric Critical Care Medicine, 16(7), 522–531.
  6. Odetola, F. O., Gebremariam, A., Freed, G. L., & Singer, D. (2007). Patient and hospital correlates of clinical outcomes and resource utilization in severe pediatric sepsis. Pediatrics, 119(3), 487–494.
  7. Carcillo, J. A., & Fields, A. I. (2002). Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Critical Care Medicine, 30(6), 1365–1378.
  8. de Caen, A. R., Berg, M. D., Chameides, L., Gooden, C. K., Hickey, R. W., Scott, H. F., ... & Topjian, A. A. (2015). Part 12: Pediatric advanced life support. Circulation, 132(18 Suppl 2), S526–S542.
  9. Ventura, A. M., Shieh, H. H., Bousso, A., Góes, P. F., de Cássia F. de Souza, D., & de Carvalho, W. B. (2015). Double-blind prospective randomized controlled trial of dopamine versus epinephrine as first-line vasoactive drugs in pediatric septic shock. Critical Care Medicine, 43(11), 2292–2302.
  10. Ramaswamy, K. N., Singhi, S., Jayashree, M., & Bansal, A. (2016). Double-blind randomized clinical trial comparing dopamine and epinephrine in pediatric fluid-refractory septic shock. Pediatric Critical Care Medicine, 17(11), e502–e512.
  11. Inwald, D. P., Tasker, R. C., Peters, M. J., & Nadel, S. (2009). Emergency management of children with severe sepsis in the United Kingdom: The results of the Paediatric Intensive Care Society sepsis audit. Archives of Disease in Childhood, 94(5), 348–353.
  12. Maitland, K., Kiguli, S., Opoka, R. O., Engoru, C., Olupot-Olupot, P., Akech, S. O., ... & FEAST Trial Group. (2011). Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine, 364(26), 2483–2495.
  13. Semler, M. W., Self, W. H., Wanderer, J. P., Ehrenfeld, J. M., Wang, L., Byrne, D. W., ... & SALT-ED and SMART Investigators. (2018). Balanced crystalloids versus saline in critically ill adults. New England Journal of Medicine, 378(9), 829–839.
  14. Self, W. H., Semler, M. W., Wanderer, J. P., Wang, L., Byrne, D. W., Collins, S. P., ... & SALT-ED Investigators. (2018). Balanced crystalloids versus saline in noncritically ill adults. New England Journal of Medicine, 378(9), 819–828.
  15. Nakagawa, S., & Shime, N. (2014). Respiratory rate criteria for pediatric systemic inflammatory response syndrome. Pediatric Critical Care Medicine, 15(2), 182–189.
  16. National High Blood Pressure Education Program Working Group. (2004). The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics, 114(2 Suppl 4th Report), 555–576.
  17. Scott, H. F., Donoghue, A. J., Gaieski, D. F., Marchese, R. F., Mistry, R. D., & Nadkarni, V. M. (2016). The utility of lactate clearance as a predictor of outcomes in pediatric sepsis and septic shock. Journal of Pediatrics, 170, 254–260.
  18. Topjian, A. A., & Berg, R. A. (2019). Pediatric cardiac arrest and post-resuscitation care. New England Journal of Medicine, 381(20), 1941–1951.
  19. MacLaren, G., Butt, W., Best, D., & Donath, S. (2011). Central extracorporeal membrane oxygenation for refractory pediatric septic shock. Pediatric Critical Care Medicine, 12(2), 133–136.
  20. Rajagopal, S. K., Almond, C. S., Laussen, P. C., Rycus, P. T., & Thiagarajan, R. R. (2013). Extracorporeal membrane oxygenation for pediatric refractory septic shock. Critical Care Medicine, 41(8), 2014–2022.
  21. Nguyen, T. C., & Carcillo, J. A. (2006). Pathophysiology and treatment of septic shock in neonates. Clinics in Perinatology, 33(2), 219–238.
  22. Polin, R. A., & Papile, L. A. (2014). Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics, 133(5), 1006–1015.
  23. Zimmerman, J. J., Banks, R., Berg, R. A., Zuppa, A., Newth, C. J., Wessel, D. L., ... & Eunice Kennedy Shriver NICHD Collaborative Pediatric Critical Care Research Network. (2017). Critical illness factors associated with long-term mortality and health-related quality of life in pediatric sepsis survivors. JAMA Pediatrics, 171(8), 1–9.
  24. Hartman, M. E., Linde-Zwirble, W. T., Angus, D. C., & Watson, R. S. (2013). Trends in the epidemiology of pediatric severe sepsis. Pediatric Critical Care Medicine, 14(7), 686–693.
  25. Farris, R. W. D., Weiss, N. S., Zimmerman, J. J., & the LAPSE Investigators. (2021). Long-term outcomes after pediatric sepsis: The LAPSE study. Critical Care Medicine, 49(4), 1–12.